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1. Introduction 
Multicomponent process1-atom economy2-catalysis3 
constitutes three paramount milestones in organic chemistry 
today. Methodologies involving them constitute a clear trend of 
innovation in both laboratory and industrial scale. Many 
reactions do not waste atoms during their whole process, 
cycloadditions being the most frequently employed.4 In addition, 
a large number of domino/multicomponent cycloadditions are 
found in the literature with very interesting perspectives and 
applications, especially when a multifunctionalization can be 
introduced in the final structure. 1,3-Dipolar cycloadditions (1,3-
DC)5,6  involving metallo-azomethine ylides and electrophilic 
alkenes are appropriate to execute this three concepts with high 
efficiency.7 With this favourable features, examples of 
multicomponent 1,3-DC of azomethine ylides are frequently 
described nowadays.8,9 Firstly, the 1,3-dipole precursor (normally 
an imino ester) can be obtained in situ by imine formation from 
the corresponding aldehyde and the α-amino ester. Second, the 
metal catalyst fixs the geometry of the dipole favouring a high 
stereocontrol during the dipolarophile approach and operates 
under milder reaction conditions. The result of these 
cycloadditions are polysubstituted pyrrolidines or proline 
derivatives with an aromatic or heteroaromatic ring at the 5-
position, which are very interesting molecules in many scientific 
areas.
10
 In addition, the synthesis of pyrrolizidine alkaloids has 
been achieved, employ a 1,3-dipolar cycloaddition (1,3-DC) 
using mainly nitrones11 or azomethine ylides.12,13 
In a preliminary work14 the thermal multicomponent 1,3-DC 
of diethyl aminomalonate or α-amino esters with ethyl glyoxylate 
and dipolarophiles could be performed by in situ formation of the 
imino ester.14,15,16 In order to improve the diastereoselectivity,  
the lowering of the temperature by the employment of metal salts 
for the enantioselective multicomponent 1,3-DC of imino esters 
and different dipolarophiles can be achieved.17 In this work we 
described the use of silver salts as catalysts for the room 
temperature multicomponent 1,3-DC of ethyl glyoxylate and also 
other 2-oxoaldehydes such as 2,2-dimethoxyacetaldehyde and 
phenylglyoxal for the synthesis of prolinates with different 
carbonyl groups at the 5-position of the pyrrolidine ring. 
  
2. Results and Discussion 
2.1. 1,3-DC with ethyl glyoxylate 
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The silver-catalyzed multicomponent reaction between ethyl glyoxylate, 2,2-dimethoxyacetaldehyde, 
or phenylglyoxal as aldehyde components with a α-amino ester hydrochloride and a dipolarohile in the 
presence of triethylamine is described. This domino process takes place at room temperature by in situ 
liberation of the α-amino ester followed by the formation of the imino ester, which is the precursor of 
a metalloazomethine ylide. The cycloaddition of this species and the corresponding dipolarophile 
affords polysubstituted proline derivatives. Ethyl glyoxylate reacts with glycinate, alaninate, 
phenylalaninate and phenylglycinate at room temperature in the presence of representative 
dipolarophiles affording endo-2,5-cis-cycloadducts in good yields and high diastereoselection.  In 
addition, 2,2-dimethoxyacetaldehyde is evaluated with the same amino esters and dipolarophiles, 
under the same mild conditions, generating the corresponding endo-2,5-cis-cycloadducts with higher 
diastereoselections than the obtained in the same reactions using ethyl glyoxylate. In the case of
phenylglyoxal the corresponding 5-benzoyl-endo-2,5-cis cycloadducts are obtained in short reaction 
times and similar diasteroselection. 






















 For the optimization studies, ethyl glyoxylate, N-
methylmaleimide (NMM) and glycine ethyl ester hydrochloride 
were allowed to react in the presence of triethylamine (1.1 equiv) 
and silver salt (5 mol%) in toluene at room temperature (Scheme 
1, Table 1). The presence of silver salt was crucial because in its 
absence the reaction failed at room temperature (Table 1, entry 
1). When the reaction was performed in toluene, compound 1a 
was obtained as a 3:1 cis/trans pure mixture independently of the 
silver salt employed (Table 1, entries 2-7). All the silver salts 
tested such as AgSbF6, AgOTf (OTf = triflate), AgOTfa (OTfa = 
trifluoroacetate), AgOBz, and Ag2CO3 afforded good conversions 
with very pure crude products. In this sense, AgOAc was selected 
due to the high conversion achieved (>98%, Table 1, entry 5). 
The effect of the reaction temperature in the diastereomeric ratio 
of the product 1a was also surveyed finding identical dr at 25 ºC 
than at 0 ºC (Table 1, compare entries 5 and 8). This crude 
mixture was not so pure when the reaction was run in DCM, 
THF, Et2O, or EtOH (Table 1, entries 9-12). Copper(II) 
perchlorate and triflate can be also used although secondary 




Scheme 1. Optimization of the 1,3-DC between ethyl glycinate, ethyl 
glyoxylate, and NMM catalyzed by silver salts in different solvents. 
 
Table 1. Optimization of the 1,3-DC between ethyl glycinate, 
ethyl glyoxylate, and NMM catalyzed by silver salts.a 
Entry AgX Solvent Conv. (%)b cis-1/trans-1c 
1 ____ PhMe <5 ___ 
2 AgSbF6 PhMe 86d 3/1 
3 AgOTf
 
PhMe 89d 3/1 
4 AgOTfa
 
PhMe 91d 3/1 
5 AgOAc
 
PhMe >98d 3/1 
6 AgOBz
 
PhMe 95d 3/1 
7 Ag2CO3 PhMe 95d 3/1 
8 AgOAc
 
PhMee 95d 3/1 
9 AgOAc
 
DCM 95f 3/1 
10 AgOAc
 
THF 92 f 3/1 
11 AgOAc
 
EtOH 89f 2.5/1 
12 AgOAc
 
Et2O 95d 3/1 
13 Cu(ClO4)2 PhMe 90 f <3/1 
14 Cu(OTf)2 PhMe 90f <3/1 
a
 Ethyl glyoxylate (50% w solution in toluene), ethyl aminoglycinate 
hydrochloride and NMM (1:1:1), triethylamine (1.1 equiv) and the silver salt 
(5 mol%) were dissolved in toluene and the mixture allowed to react at 25 ºC 
for 19 h.  
b Obtained by analysis of crude 1H NMR spectra.  
c
 Determined by 1H NMR analysis. 
d Crude product was very pure by 1H NMR.  
e Reaction performed at 0 ºC.  
f Several impurities  were observed by 1H NMR. 
 
 With the selected reaction conditions in hand we study the 
scope of this multicomponent catalyzed process starting from 
ethyl glyoxylate, different maleimides and ethyl glycinate 
(Scheme 2 and Table 2, entries 1-3). N-Benzylmaleimide (NBM) 
afforded a cis/trans 3:1 pure mixture of 1b in excellent yield 
(Table 2, entry 2). In both examples (NMM and NBM), chemical 
yields and diastereomeric ratios were higher than under thermal 
reactions.14 However, with N-phenylmaleimide (NPM) the same 
diastereomeric ratio in 1c was identified (cis/trans 4:1) 
independently of the thermal or silver-catalyzed used method 
being the chemical yield sensibly higher for the last reaction 
conditions (Table 2, entry 3). The relative stereochemistry of the 
stereoisomers 1a-c involving reactions with ethyl glyoxylate was 
drawn according to the comparison with previously published 
data (X-ray diffraction analysis and NMR experiments). The 
control of the geometry of the 1,3-metallodipole by the silver 
cation is noticeable in this reaction allowing the reaction course 
through a W,W-shape metallodipole A, which afforded 2,5-cis-
adducts 1 rather than the W,S-shape metallodipole A giving 2,5-
trans-adducts 1 (Scheme 3). 
 
Scheme 2. Silver-catalyzed 1,3-DC of α-amino esters and ethyl glyoxylate 
with dipolarophiles. 
 
Scheme 3. Metallodipole conformations derived from glycine ethyl ester and 
ethyl glyoxylate 
 
Due to the importance of the quaternary α−amino acids in many 
scientific areas, the multicomponent 1,3-DC employing several 
α-substituted α-amino esters were tested. When alanine methyl 
ester hydrochloride was allowed to react with ethyl glyoxylate 
and NMM under the optimized reaction conditions endo-cis-
cycloadduct 2a was isolated in 59% yield as unique 
diastereoisomer with lower yield than the obtained in the thermal 
process14 (Scheme 2, Table 2, entry 4). No difference was 
observed in the reactions (thermal14 or silver-catalyzed) involving 
methyl acrylate, dimethyl fumarate, and 1,2-
bis(phenylsulfonyl)ethylene (Scheme 2, Table 2, entries 5-7). 
The diastereoselective transformation occurred for both (E)-
configured alkenes furnishing endo-cis-2d and endo-cis-2e in 55 
and 65% yields, respectively (Table 2, entries 5 and 6). A 
mixture of three stereoisomers (cis- and trans-2f and 2f’) was 
obtained in 45% yield in the case of methyl acrylate and alanine 
methyl ester hydrochloride (Scheme 2, Table 2, entry 7). 
According to these results W,W-shape metallodipole B (Scheme 
4) is mainly originated by the silver cation. We can assume that 
the preferred attack occurred through the less hindered γ-position 
















Scheme 4. Metallodipole conformations derived from α-substituted amino 
esters and ethyl glyoxylate. 
 
 Phenylalanine ethyl ester hydrochloride smoothly reacted with 
maleimides at room temperature using ethyl glyoxylate and silver 
acetate (5 mol%). Again, endo-cis cycloadducts 3a-c were 
isolated diastereoselectively in good chemical yields (Scheme 2, 
Table 2, entries 8-10). However, when more sterically hindered 
dimethyl fumarate and 1,2-bis(phenylsulfonyl)ethylene (BPSE) 
were employed as dipolarophiles, lower chemical yields were 
obtained than under thermal conditions. The reaction was 
diastereoselective affording exo-cis-cycloadduct 3d and endo-cis-
cycloadduct 3e, respectively (Scheme 2, Table 2, entries 11 and 
12). With all this information W,W-shape type metallodipole B 
(Scheme 4) should be mainly generated during the reaction 
course employing the phenylalaninate. 
 In the case of phenylglycine methyl ester, the major endo-cis 
compound 4a was obtained through a W,W-shape metallodipole 
B geometry (Scheme 4). The chemical yield of the reaction 
carried out with methyl acrylate was 45% affording a 1:1 mixture 
of the cis- and trans-adducts 4f, which demonstrated a higher 
proportion of the Sγ-shape metallodipole B during the reaction 
course (Scheme 2 and 4, Table 2, entry 14). In both examples, the 
diastereomeric ratio was slightly higher than the originally 
reported for the analogous thermal processes14 2.5:1 vs 2:1 and 
2:1 vs 1:1, respectively. E-1,2-Disubstituted electrophilic alkenes 
were not very appropriate substrates for the cycloaddition using 
silver-catalyzed conditions. In both diastereoselective 
transformations chemical yields were lower than the results 
obtained for the thermal processes.14 The exo-adducts 4d and 4e 
predominated (Scheme 2, Table 2, entries 15 and 16). The bulkier 
phenylsulfonyl group, presumably preferred to react through the 
S-shape metallodipoles B rather than W-shaped one (Scheme 4). 
We anticipate that working with different ester groups at 2- 
and 5- positions as occurred in final α-substituted prolines 2, and 
4 would allow to transform chemoselectively one of them (less 
sterically hindered) leaving the other ester group unaltered. 
 
2.2. 1,3-DC with 2,2-dimethoxyacetaldehyde 
 Following the same strategy and with the idea to 
introduce a new protected formyl group at the 5-position of the 
pyrrolidine ring, we next evaluated the scope of the 
multicomponent process using 2,2-dimethoxyacetaldehyde as 
imine precursor. Ethyl glycinate, maleimides and 2,2-
dimethoxyacetaldehyde was an appropriate combination to be 
catalyzed by AgOAc (Scheme 5 and Table 3). Again the presence 
of the silver salt was crucial for obtaining total reaction 
conversions. In general, the reaction was diastereoselective 
(>50:1 ratio by 1H NMR) and the chemical yields of endo-2,5-
cis-adducts 5 were satisfactory (71-74%) (Scheme 5, Table 3, 
entries 1-3). These results indicated that stabilization of the 
W,W-shape metallodipole type-C during the reaction course is 
very important, probably due to a stronger coordination between 
the two methoxy groups rather than the carbonyl group of the 
glyoxylate (Scheme 6). The unfruitful multicomponent reaction 
of acetaldehyde glycine methyl ester hydrochloride and NMM 
confirmed the important role of this extra-coordination of dipole 
C.  
In addition, the microwave-assisted reaction at 110 ºC was 
performed using NMM as example. This thermal transformation 
produced a 2:1 mixture of cis:trans endo-cycloadducts 5a in 65% 
yield (Scheme 7). In this last example, the thermal [1,2]-
prototropy did not control the geometry of the dipole as expected 
due to the existence of S-dipole D in high proportions (Scheme 
8). The contrast of this low diastereoselection with the good 
result achieved in the silver-catalyzed process prompted us to 
discard a parallel study of the thermal reaction conditions.  
 
Scheme 5. Silver-catalyzed 1,3-DC of α−amino esters and 2,2-




Scheme 6. Metallodipole conformation derived from 1,3-DC of α-substituted 
amino esters and 2,2-dimethoxyacetaldehyde. 
 

















Scheme 8. Dipole conformation for thermal 1,3-DC of ethyl glycinate, 
NMM and 2,2-dimethoxyacetaldehyde. 
 Almost complete diastereoselection was detected when alanine 
derivative and 2,2-dimethoxyacetaldehyde were allowed to react 
with NMM and dimethyl fumarate. Compound endo-2,5-cis-6a 
was isolated in 89% yield whilst endo-2,5-cis-6d was obtained in 
a lower 43% yield (Scheme 5, Table 3, entries 4 and 5). In this 
last reaction, apart from starting reagents, small amounts of other 
secondary products were hardly detected. When methyl acrylate 
was tested as dipolarophile an equimolar mixture of endo-2,5-cis- 
and exo-2,5-cis-stereoisomers 6f, together with an unidentified 
diastereoisomer was obtained. Stereoisomers 6f were isolated 
after purification in 85% yield (Scheme 5, Table 3, entry 6). 
Phenylalanine ethyl ester derivative afforded endo-cis-
compounds 7a-c in very good chemical yields and excellent 
diastereoselections upon domino reaction with a maleimide and 
2,2-dimethoxyacetaldehyde (Scheme 5, Table 3, 7-9). The crude 
reaction 1H NMR spectra revealed that any other stereoisomer 
was formed.  
 Besides, a considerable lower diastereoselection was obtained 
when dimethyl fumarate was employed as dipolarophile. The 3:1 
endo-cis-7d:exo-cis-7d ratio was determined by 1H NMR and the 
relative configuration assigned according to nOe experiments 
(Scheme 5, entry 10). At this point the reaction with 1,2-
bis(phenylsulfonyl)ethylene completely failed, which confirms 
the low chemical yield observed in precedent reactions possibly  
due to steric reasons. The reactions dealing with phenylglycine 
derivative were surveyed obtaining very complex crude reaction 
products with many side products. 
Unlike the behaviour observed with ethyl glyoxylate, 2,2-
dimethoxyacetaldehyde reacted in the presence of NMM and 
diethyl aminomalonate in good yield (70%) and high 
diastereomeric ratio affording mainly all-cis compound 8 
(Scheme 5, Table 3, entry 11).  
 
2.3. 1,3-DC with phenylglyoxal 
The benzoyl group was introduced at the 5-position of the 
pyrrolidine ring by employing phenylglyoxal as aldehyde 
component.16 The reactions were carried out under identical 
conditions described in the two previous sections, silver salt 
being necessary for the success of the process (Scheme 9 and 
Table 4).  
 
 
Scheme 9. Silver-catalyzed 1,3-DC of α-amino esters and phenylglyoxal with 
dipolarophiles. 
The reactions involving glycine methyl ester hydrochloride 
and maleimides afforded cycloadducts endo-2,5-cis-9 in 
moderate to good chemical yields (Table 4, entries 1-3). Alanine 
or phenylalanine derivatives and maleimides also gave the 
expected 2,5-cis-products 10a, 11a and 11c, in good yields and 
excellent endo-diastereoselection (Table 4, entries 4-6).  Methyl 
fumarate reacted in the presence of the phenylalanine giving 
compound 11d as unique stereoisomer in 47% yield. The 
multicomponent reaction of NMM and diethyl aminomalonate 
occurred in moderate yield (40%) and high diastereomeric ratio 
affording mainly all-cis compound 12 (Scheme 9, Table 4, entry 
8). In some examples we observed a slight decomposition of the 
cycloadducts during the chromatographic separation and a 
deactivation of flash silica-gel was previously done with 
triethylamine. 
The intermediacy of the W,W-metallodipole F as 
intermediate species (Figure 1) can justify the relative cis-




Figure 1. Metallodipole conformations derived from α-substituted amino 






The silver catalyzed endo-diastereoselective multicomponent 1,3-
DC using α-amino esters, dipolarophiles and functionalized 
aldehydes such as ethyl glyoxylate, 2,2-dimethoxyacetaldehyde, 
or phenylglyoxal was successfully accomplished. In general, in 
the catalyzed process with ethyl glyoxylate the endo-2,5-cis-
diastereoselections and chemical yields were in general better 
than those obtained under thermal conditions. When the reaction 
was performed with 2,2-dimethoxyacetaldehyde or 
phenylglyoxal the silver-catalyzed conditions for the 
cycloaddition gave the best results. In this case, higher 2,5-cis-
diastereoselections than in the reactions involving ethyl 



















Table 2. Scope of the silver catalyzed 1,3-DC between ethyl glyoxylate with different α-imino esters and dipolarophiles.a 
Entry R1 R2 Dipolarophile Product Yield (%)b, drc 











































































































































   
 
a
 Ethyl glyoxylate (1M solution in toluene), amino ester hydrochloride and the dipolarophile (1:1:1), triethylamine (1.1 equiv) and the silver salt (5 mol%) were 
dissolved in toluene and the mixture allowed to react at 25 ºC for 1 d.  
b Isolated yield after column chromatography.  
c In brackets data of the process performed under thermal conditions (ref.14). 















Table 3. Scope of the silver catalyzed 1,3-DC between 2,2-dimethoxyacetaldehyde with different α-imino esters and dipolarophiles.a  















































Et Dimethyl fumarate 
 
66 













   
 
a
 2,2-Dimethoxyacetaldehyde, amino ester hydrochloride and the dipolarophile (1:1:1), triethylamine (1.1 equiv) and the silver salt (5 mol%) were dissolved in 
toluene and the mixture allowed to react at 25 ºC for 1 d.  
b Isolated yield after column chromatography.  
c Thermal MW-reaction afforded a 2:1 mixture of diastereoisomers (see text).  















Table 4. Scope of the silver catalyzed 1,3-DC between phenylglyoxal with different α-imino esters and dipolarophiles.a  











3 H Mr NPM 
 
70 















Et Dimethyl fumarate 
 
47 





   
 
a
 Phenylglyoxal, amino ester hydrochloride and the dipolarophile (1:1:1), triethylamine (1.1 equiv) and the silver salt (5 mol%) were dissolved in toluene and the 
mixture allowed to react at 25 ºC for 1 d.  
b Isolated yield after column chromatography.  





3. Experimental section 
3.1. General 
The structurally most important peaks of the IR spectra (recorded 
using a Nicolet 510 P-FT) are listed. 1H NMR (300 MHz) and 13C 
NMR (75 MHz) spectra were obtained using a Bruker AC-300 with 
CDCl3 as solvent and TMS as internal standard unless otherwise 
stated. Low-resolution electron impact (GC-EI) mass spectra were 
obtained at 70 eV using a Shimadzu QP-5000, and high-resolution 
mass spectra were obtained using a Finnigan VG Platform. 
Analytical TLC was performed using Schleicher & Schuell 
F1400/LS silica gel plates, and the spots were visualized under UV 
light (λ=254 nm). Melting points were determined with a Reichert 
Thermovar hot plate apparatus and are uncorrected. For flash 
chromatography, Merck silica gel 60 (0.040–0.063 mm) was 
employed. 
3.2. General procedure for the synthesis of cycloadducts 
Ethyl glyoxylate (100 µL, 0.5 mmol, 50% in toluene) or 2,2-
dimethoxyacetaldehyde (75µL, 0.5 mmol, 50% in water), or 
phenylglyoxal·monohydrate (58 µL, 0.5 mmol); diethyl 
aminomalonate hydrochloride or the amino acid ethyl ester 
hydrochloride (0.5 mmol), the corresponding dipolarophile (0.5 
mmol), AgOAc (4.1 mg, 0.025 mmol) and triethylamine (90 µL, 
0.55 mmol) were dissolved in toluene (4 mL). The reaction vessel 
was covered with an aluminum foil in order to prevent the light 
exposure. Once the reaction was judged complete after a TLC test 
the solvent was evaporated under reduced pressure and the residue 














MgSO4. After evaporation the residue was purified by flash 
chromatography (silica gel) to afford the corresponding product. The 
reaction involving ethyl glyoxylate and 2,2-dimethoxyacetaldehyde 
were scaled up 10 times to afford endo-cis-3a and endo-cis-5a in 
80% and 75%, respectively. 
4.2.1. Diethyl (1R*,3S*,3aR*,6aS*)-5-methyl-4,6-dioxooctahydro 
pyrrolo[3,4-c]pyrrole-1,3-dicarboxylate (endo-cis-1a).14 Sticky 
yellow oil; IR (neat)  νmax 2984, 1699, 1595 cm-1; 1H NMR δH: 1.33 
(t, J = 7.2 Hz, 6H, 2xCO2CH2CH3), 2.94 (s, 3H, NCH3), 3.57 [m, 2H, 
2xCHCH(CO2Et)NH], 3.97 [m, 2H, 2xCH(CO2Et)NH], 4.30 (q, J = 
7.2 Hz, 4H, 2xCO2CH2CH3), NH nd; 13C NMR δC: 14.2 
(2xCO2CH2CH3),  25.5 (NCH3), 50.0 [2xCHCH(CO2Et)NH], 61.9 
(2xCO2CH2CH3), 63.1 [2xCH(CO2Et)NH], 169.0 (2xCO2CH2CH3), 
175.0 (2xCON); MS (EI-GC) m/z: 298 (M++1, 1%), 226 (12), 225 
(100), 179 (32), 151 (53), 94 (44), 67 (12); HRMS calculated for 
C13H18N2O6: 298.1155, found: 298.1148.  
4.2.2. Diethyl (1R*,3R*,3aR*,6aS*)-5-methyl-4,6-dioxooctahydro 
pyrrolo[3,4-c]pyrrole-1,3-dicarboxylate (endo-trans-1a).14 Sticky 
yellow oil; IR (neat) νmax 2984, 1774, 1731, 1595 cm-1; 1H NMR δH: 
1.33 (t, J = 7.2 Hz, 3H, CO2CH2CH3), 1.35 (t, J = 7.2 Hz, 3H, 
CO2CH2CH3), 2.98 (s, 3H, NCH3), 3.56 [deform. dd, J = 8.0, 8.0 Hz, 
1H, CHCH(CO2Et)NH], 3.64 [dd, J = 8.0, 1.2 Hz, 1H, 
CHCH(CO2Et)NH], 4.13 [d, J = 8.0 Hz, 1H, CH(CO2Et)NH],  4.24 
(q, J = 7.2 Hz, 2H, CO2CH2CH3), 4.27–4.35 (m, 3H, CO2CH2CH3 
and CH(CO2Et)NH], NH nd; 13C NMR δC: 14.2, 14.3 
(2xCO2CH2CH3), 25.5 (NCH3), 47.6 [CHCH(CO2Et)NH], 48.8 
[CHCH(CO2Et)NH], 61.8, 62.0 (2xCO2CH2CH3), 62.2 
[CH(CO2Et)NH], 62.4 [CH(CO2Et)NH], 169.7, 171.7 (2xCO2), 
175.4, 176.6 (2xCON); MS (EI-GC) m/z: 298 (M++1, 1%), 226 (12), 
225 (100), 179 (17), 151 (40), 94 (40), 68 (10), 67 (13),; HRMS 
calculated for C13H18N2O6: 298.1155, found: 298.1148.  
4.2.3. Diethyl (1R*,3S*,3aR*,6aS*)-5-benzyl-4,6-dioxooctahydro 
pyrrolo[3,4-c]pyrrole-1,3-dicarboxylate  (endo-cis-1b).14 Sticky 
yellow oil; IR (neat)  νmax 2984, 1740, 1705 cm-1; 1H NMR δH: 1.28 
(t, J = 7.1 Hz, 6H, 2xCO2CH2CH3), 3.54 [m, 2H, 
CHCH(CO2Et)NH], 3.94 [m, 2H, CH(CO2Et)NH], 4.24 (q, J = 7.1 
Hz, 4H, 2xCO2CH2CH3), 4.58 (s, 2H, CH2Ph), 7.18–7.38 (m, 5H, 
ArH); 13C NMR δC: 14.1 (2xCO2CH2CH3), 43.0 (CH2Ph), 49.8 
[2xCHCH(CO2Et)NH], 62.0 (2xCO2CH2CH3), 63.0 
[2xCH(CO2Et)NH], 128.1, 128.6, 128.7, 135.2 (ArC), 168.8 
(2xCO2CH2CH3), 174.6 (CON); MS (EI-GC) m/z: 374 (M++1, 2%), 
302 (18), 301 (100), 227 (50), 94 (23), 91 (47), 68 (11); HRMS 
calculated for C19H22N2O6: 374.1478, found: 374.1470. 
4.2.4. Diethyl (1R*,3R*,3aR*,6aS*)-5-benzyl-4,6-dioxooctahydro 
pyrrolo[3,4-c]pyrrole-1,3-dicarboxylate (endo-trans-1b).14 Sticky 
yellow oil; IR (neat) νmax 2990, 1740, 1700 cm-1; 1H NMR δH: 1.23–
1.38 (m, 6H, 2xCO2CH2CH3), 3.64 (dd, J = 8.0, 1.4 Hz,1H, 
CHCH(CO2Et)NH), 4.10–4.33 [m, 6H, CHCH(CO2Et)NH  and 
CH(CO2Et)NH and 2xCO2CH2CH3], 4.52–4.69 (m, 3H, CH2Ph and 
CH(CO2Et)NH), 7.18–7.40 (m, 5H,ArH); 13C NMR δC: 14.2, 14.3 
(2xCO2CH2CH3), 43.1 (CH2Ph), 48.8 [CHCH(CO2Et)NH], 49.9 
[CHCH(CO2Et)NH], 61.8, 62.0 (2xCO2CH2CH3), 62.2 
[CH(CO2Et)NH], 62.5 [CH(CO2Et)NH], 128.1, 128.8, 129.1, 135.4 
(ArC), 169.6, 171.7 (2xCO2CH2CH3), 175.0, 176.3 (2xCON); MS 
(EI-GC) m/z: 374 (M++1, 2%), 302 (18), 301 (100), 227 (31), 94 
(20), 91 (44), 68 (13); HRMS calculated for C19H22N2O6: 374.1478, 
found: 374.1470.  
4.2.5. Diethyl (1R*,3S*,3aR*,6aS*)-4,6-dioxo-5-phenyloctahydro 
pyrrolo[3,4-c]pyrrole-1,3-dicarboxylate (endo-cis-1c).14 Colorless 
needles, mp = 123-125 ºC (from hexane/CDCl3); IR (neat) νmax 2980, 
1741, 1732, 1708 cm-1; 1H NMR δH: 1.32 (t, J = 7.2 Hz, 6H, 
2xCO2CH2CH3), 3.05 (t, J = 12.7 Hz, 1H, NH), 3.71 [m, 2H, 
2xCHCH(CO2Et)NH], 4.06 [m, 2H, CH(CO2Et)NH], 4.29 (q, J = 7.2 
Hz, 4H, 2xCO2CH2CH3), 7.19–7.22 (m, 2H, ArH), 7.37–7.46 (m, 
3H, ArH); 13C NMR δC: 14.0 (2xCO2CH2CH3), 49.9 
[2xCHCH(CO2Et)NH], 62.1 (2xCO2CH2CH3), 63.4 
[2xCH(CO2Et)NH], 126.5, 128.9, 129.2, 131.3 (ArC), 169.0 
(2xCO2CH2CH3), 174.1 (2xCON); MS (EI-GC) 360 m/z (M++1, 
3%), 288 (19), 287 (100), 94 (45), 68 (13), 67 (11); HRMS 
calculated for C18H20N2O6: 360.1301, found: 360.1291. 
4.2.6. Diethyl (1R*,3R*,3aR*,6aS*)-4,6-dioxo-5-phenyloctahydro 
pyrrolo[3,4-c]pyrrole-1,3-dicarboxylate  endo-trans-1c).14 Colorless 
needles mp = 105-107 ºC (from hexane/CDCl3); IR (neat) νmax 2976, 
1712 cm-1; 1H NMR δH: 1.20–1.32 (m, 6H, 2xCO2CH2CH3), 2.85 
(br. s, 1H, NH), 3.68 [deform. dd, J = 8.1, 8.1 Hz, 1H, 
CHCH(CO2Et)NH], 3.83 [d, J = 8.1, 1H, CHCH(CO2Et)NH], 4.25 
[m, 5H, 2xCO2CH2CH3 and CH(CO2Et)NH], 4.42 [s, 1H, 
CH(CO2Et)NH], 7.23–7.27 (m, 2H, ArH), 7.38–7.47 (m, 3H, ArH); 
13C NMR δC: 14.0, 14.1 (2xCO2CH2CH3), 47.6 [CHCH(CO2Et)NH], 
49.9 [CHCH(CO2Et)NH], 61.9, 62.1 (2xCO2CH2CH3), 62.3 
[CH(CO2Et)NH], 62.9 [CH(CO2Et)NH], 126.4, 128.8, 129.1, 131.5 
(ArC), 169.8, 171.4 (2xCO2CH2CH3), 174.6, 175.6 (2xCON); MS 
(EI-GC) 360 m/z: (M++1, 4%), 67 (10), 68 (13), 94 (40), 287 (100), 
288 (17); HRMS calculated for C18H20N2O6: 360.1301, found: 
360.1291. 
4.2.7. 3-Ethyl 1-methyl (1S*,3R*,3aS*,6aR*)-1,5-dimethyl-4,6-
dioxooctahydropyrrolo[3,4-c]pyrrole-1,3-dicarboxylate endo-cis-
2a).14 Sticky pale yellow oil; IR (neat) νmax 2983, 2955, 1777, 1735, 
1697 cm-1; 1H NMR δH: 1.36 (t, J = 7.2 Hz, 3H, CO2CH2CH3), 1.49 
[s, 3H, C(CO2CH3)CH3], 2.93 (s, 3H, NCH3), 3.25 [d, J = 8.0 Hz, 
1H, CHC(CO2Me)CH3], 3.37 (d, J = 12.5 Hz, 1H, NH),  3.63 
[deform. dd, J = 8.0, 8.0 Hz, 1H, CHCH(CO2Et)NH], 3.83 (s, 3H, 
CO2CH3), 4.14 [dd, J = 12.5, 8.0, Hz, 1H, CH(CO2Et)NH], 4.30 (q, J 
= 7.2 Hz, 2H, CO2CH2CH3 ); 13C NMR δC: 14.2 (CO2CH2CH3), 24.6 
[C(CO2CH3)CH3], 25.4 (NCH3), 50.4 [CHCH(CO2Et)NH], 53.1 
[CHC(CO2Me)CH3], 62.0 (CO2CH3), 62.1 (CO2CH2CH3), 69.4 
[CH(CO2Me)CH3], 169.5, 171.7 (2xCO2), 175.0, 175.2 (2xCON); 
MS (EI-GC) m/z: 298 (M++1, <1%), 239 (67), 225 (39), 165 (100), 
108 (43), 81 (10), 80 (21); HRMS calculated for C13H18N2O6: 
298.1165, found: 298.1163.  
4.2.8. 5-Ethyl 2,3,4-trimethyl (2S*,3S*,4S*,5R*)-2-
methylpyrrolidine-2,3,4,5-tetracarboxylate (endo-cis-2d).14 Pale 
yellow oil; IR (neat) νmax 2986, 2954, 2907, 1730, 1729 cm-1; 1H 
NMR δH: 1.27 (t, J = 7.1 Hz, 3H, CO2CH2CH3), 1.60 [s, 3H, 
C(CO2CH3)CH3], 3.24 [d, J = 10.0 Hz, 1H, CHC(CO2Me)Me], 3.64, 
3.68, 3.74 (3s, 3H, CO2CH3), 3.78 [dd, J = 10.0, 8.1 Hz, 1H, 
CHCH(CO2Et)NH], 4.02 [d, J = 8.1 Hz, 1H, CH(CO2Et)NH], 4.15 
(q, J = 7.1, Hz, 2H, CO2CH2CH3), NH nd; 13C NMR δC: 14.2 
(CO2CH2CH3), 24.9 [C(CO2CH3)CH3], 49.6 [CHC(CO2Me)Me], 
52.3, 52.6 52.7 (3xCO2CH3), 56.8 [CHCH(CO2Et)NH], 61.7 
[CH(CO2Et)NH], 61.8 (CO2CH2CH3), 68.4 [C(CO2Me)Ph], 170.6, 
172.3, 173.0, 173.8 (4xCO2); MS (EI-GC) m/z: 331 (M++1, <2%), 
272 (65), 258 (19), 262 (19), 241 (10), 240 (82), 226 (99), 212 (80), 
198 (60), 180 (10), 167 (11), 166 (100), 154 (25), 140 (72), 139 (10), 
136 (10), 122 (10), 108 (58), 94 (11), 81 (22), 80 (27), 59 (24); 
HRMS calculated for C14H21NO8: 331.1267, found: 331.1274.  
4.2.9. 5-Ethyl 2-methyl (2R*,3R*,4R*,5S*)-2-methyl-3,4-
bis(phenylsulfonyl)pyrrolidine-2,5-dicarboxylate (endo-cis-2e).14 
Orange oil; IR (neat) νmax 2985, 2956, 2905, 1735, 1710, 1308, 1146 
cm-1; 1H NMR δH: 1.00 (t, J = 7.1 Hz, 3H, CO2CH2CH3), 1.72 [s, 
3H, C(CO2CH3)CH3], 3.72 (s, 3H, CO2CH3), 3.94 (q, J = 7.1 Hz, 2H, 
CO2CH2CH3), 4.27 [d, J = 6.5 Hz, 1H, CH(CO2Et)NH], 4.28 [d, J = 
4.5 Hz, 1H, CHC(CO2Me)Me], 5.01 [dd, J = 6.5, 4.5 Hz, 1H, 
CHCHCO2Et], 7.51–7.71 (m, 6H, ArH), 7.81–8.02 (m, 4H, ArH), 
NH nd; 13C NMR δC: 14.0 (CO2CH2CH3), 23.7 [CHC(CO2Me)CH3], 
52.7 [CH(CO2Et)NH], 61.5 (CO2CH3), 62.2 (CO2CH2CH3), 69.4 














128.4, 128.9, 129.3, 129.4, 134.2, 134.4, 138.1, 140.4 (ArC), 
170.1, 171.2 (2xCO2); MS (EI-GC) m/z: 495 (M++1, <1%), 294 (32), 
279 (21), 248 (39), 237 (14), 236 (100), 222 (26), 221 (10), 156 (11), 
128 (17), 125 (11), 108 (23), 96 (26), 95 (10), 94 (11), 81 (46), 80 
(21), 77 (14); HRMS calculated for C22H25NO8S2: 495.1022, found: 
495.1015. 
4.2.10. 2-Ethyl 3,5-dimethyl (2R*,3S*,5S*)-5-methylpyrrolidine-
2,3,5-tricarboxylate (endo-cis-2f).14 Yellowish oil; IR (neat) νmax 
2983, 2954, 1731, 1725, 1700 cm-1; 1H NMR δH: 1.26 (t, J = 7.2 Hz, 
3H, CO2CH2CH3), 1.49 [s, 3H, C(CO2CH3)CH3], 2.01 [dd, J = 12.9, 
9.8 Hz, 1H, CHHC(CO2Me)CH3], 2.64 [dd, J = 12.9, 8.3 Hz, 1H, 
CHHC(CO2Me)CH3], 3.19 [ddd, J = 9.8, 8.3, 7.1 Hz, 1H, 
CH(CO2Me)], 3.71, 3.73 (2s, 3H, CO2CH3),  3.77 [d, J = 7.1 Hz, 1H, 
CH(CO2Et)NH], 4.16 (q, J = 7.2, Hz, 2H, CO2CH2CH3, NH nd; 13C 
NMR δC: 14.3 (CO2CH2CH3), 25.9 [C(CO2CH3)CH3], 40.7 
[CH2C(CO2Me)CH3], 47.4 [CHCH(CO2Et)NH], 52.4, 52.7 
(2xCO2CH3), 61.6 (CO2CH2CH3), 63.0 [CH(CO2Et)NH], 66.3 
[C(CO2Me)CH3],  172.8, 173.5, 176.3 (3xCO2); MS (EI-GC) m/z: 
273 (M++1, <2%), 215 (11), 214 (100), 200 (30), 168 (13), 140 (33), 
108 (19), 82 (21); HRMS calculated for C12H19NO6: 273.1212, 
found: 273.1214.  
4.2.11. 2-Ethyl 3,5-dimethyl (2R*,3S*,5R*)-5-methylpyrrolidine-
2,3,5-tricarboxylate (endo-trans-2f).14 Yellowish oil; IR (neat) νmax 
2983, 2953, 1732, 1725, 1703 cm-1; 1H NMR δH: 1.25 (t, J = 7.2 Hz, 
3H, CO2CH2CH3), 1.37 [s, 3H, C(CO2CH3)CH3], 2.01 [dd, J = 13.5, 
8.0 Hz, 1H, CHHC(CO2Me)CH3], 2.68 [dd, J = 13.5, 7.2 Hz, 1H, 
CHHC(CO2Me)CH3], 3.30 [ddd, J = 8.0, 7.2, 7.0 Hz, 1H, 
CHCH(CO2Et)], 3.62, 3.73 (2s, 3H, CO2CH3),  4.03 [d, J = 7.0 Hz, 
1H, CH(CO2Et)NH], 4.15 (q, J = 7.2, Hz, 2H, CO2CH2CH3, NH nd; 
13C NMR δC: 14.2 (CO2CH2CH3), 28.3 [C(CO2CH3)CH3], 39.1 
[CH2C(CO2Me)CH3], 47.1 [CHCH(CO2Et)NH], 53.3, 53.4 
(2xCO2CH3), 61.4 (CO2CH2CH3), 62.8 [CH(CO2Et)NH], 65.4 
[C(CO2Me)CH3],  172.3, 173.6, 176.4 (3xCO2); MS (EI-GC) m/z: 
273 (M++1, <2%), 215 (12), 214 (100), 200 (33), 140 (62), 108 (20), 
99 (24), 82 (23); HRMS calculated for C12H19NO6: 273.1212, found: 
273.1215. 
4.2.12. 5-Ethyl 2,3-dimethyl (2S*,3R*,5R*)-2-methylpyrrolidine-
2,3,5-tricarboxylate (endo-cis-2f´).14 Yellowish oil; IR (neat) νmax 
2983, 2955, 1730, 1726, 1700 cm-1; 1H NMR δH: 1.26 (t, J = 7.1 Hz, 
3H, CO2CH2CH3), 1.51 [s, 3H, C(CO2CH3)CH3], 2.29–2.57 [m, 2H, 
CH2CH(CO2Et)], 2.87 [dd, J = 9.5, 8.1 Hz, 1H, CHC(CO2Me)CH3], 
3.65, 3.66 (2s, 3H, CO2CH3), 3.87 [dd, J = 8.6, 7.6 Hz, 1H, 
CH(CO2Et)NH], 4.15 (q, J = 7.1, Hz, 2H, CO2CH2CH3), NH nd; 13C 
NMR δC: 14.3 (CO2CH2CH3), 25.5 [CHC(CO2Me)CH3], 32.3 
[CH2CH(CO2Et)NH], 52.0, 52.1 (2xCO2CH3), 52.5 
[CHC(CO2Me)Me], 58.0 [CH(CO2Et)NH], 61.4 (CO2CH2CH3), 68.3 
[C(CO2Me)Me], 171.6, 172.2, 174.3 (3xCO2); MS (EI-GC) m/z: 273 
(M++1, <2%), 215 (12), 214 (100), 200 (32), 140 (62), 108 (20), 99 




3a).14  Sticky pale yellow oil; IR (neat) νmax 3030, 2982, 2936, 1779, 
1734, 1699 cm-1; 1H NMR δH: 1.32, 1.34 (2t, J = 7.2 Hz, 3H, 
CO2CH2CH3), 2.88, 3.30 (2d, J = 13.8 Hz, 2H, CH2Ph) 2.92 (s, 3H, 
NCH3), 3.38 [d, J = 8.0 Hz, 1H, CHC(CO2Et)Bn],  3.55 [deform. dd, 
J = 8.4, 8.0 Hz, 1H, CHCH(CO2Et)NH], 4.09 [d, J = 8.4, Hz, 1H, 
CH(CO2Et)NH], 4.24 (q, J = 7.2 Hz, 2H, CO2CH2CH3 ), 4.26 (q, J = 
7.2 Hz, 2H, CO2CH2CH3), NH nd; 13C NMR δC: 14.0 
(2xCO2CH2CH3), 25.4 (NCH3), 42.2 (CH2Ar), 50.4 
[CHCH(CO2Et)NH], 56.6 [CHC(CO2Et)Bn], 62.0 [CH(CO2Et)NH], 
62.1 (CO2CH2CH3), 62.3 (CO2CH2CH3) 73.6 [C(CO2Et)Bn], 127.2, 
128.3, 130.4, 135.7 (ArC)169.6, 170.1 (2xCO2), 175.0, 175.1 
(2xCON); MS (EI-GC) m/z: 388 (M++1, <1%), 315 (13), 298 (14), 
297 (100), 223 (11), 166 (45), 94 (11), 91 (17); HRMS calculated for 
C20H24N2O6: 388.1634, found: 388.1631.  
4.2.14. Diethyl (1S*,3R*,3aS*,6aR*)-1,5-dibenzyl-4,6-dioxoocta 
hydropyrrolo[3,4-c]pyrrole-1,3-dicarboxylate (endo-cis-3b).14 
Colorless prisms, mp = 127-130 ºC (from hexane/CDCl3); IR (neat) 
νmax 3030, 2989, 1741, 1719, 1699 cm-1; 1H NMR δH: 1.23 (t, J = 7.2 
Hz, 3H, CO2CH2CH3), 1.28 (t, J = 7.2 Hz, 3H, CO2CH2CH3), 2.89, 
3.31 (2d, J = 13.9 Hz, 2H, CH2Ph), 3.38 [d, J = 7.8 Hz, 1H, 
CHC(CO2Et)Bn], 3.55 [deform. dd, J = 7.8, 7.8 Hz, 1H, 
CHCH(CO2Et)NH], 4.03–4.27 (m, 5H, 2xCO2CH2CH3 and 
CH(CO2Et)NH], 4.54, 4.60 (d, J = 14.3 Hz, 2H), 7.20–7.35 (m, 10H, 
2xCH2Ph), NH nd; 13C NMR δC: 14.0, 14.1 (2xCO2CH2CH3), 42.2, 
43.0 (2xCH2Ph), 50.4 [CHCH(CO2Et)NH], 56.6 
[CHCH(CO2Et)NH], 61.9, 62.1 (2xCO2CH2CH3), 62.3 
[CH(CO2Et)NH], 73.7 [CBn(CO2Et)NH], 127.2, 128.0, 128.3, 128.6, 
128.7, 130.5, 135.2, 135.8 (ArC), 169.4, 169.9 (2xCO2CH2CH3), 
174.6, 174.7 (2xCON); MS (EI-GC) m/z: 464 (M++1, <1%), 391 
(14), 374 (22), 373 (100), 166 (22), 91 (73); HRMS calculated for 
C26H28N2O6 – C7H7: 373.1400, found: 373.1401. 
4.2.15. Diethyl (1S*,3R*,3aS*,6aR*)-1-benzyl-4,6-dioxo-5-phenyl 
octahydropyrrolo[3,4-c]pyrrole-1,3-dicarboxylate (endo-cis-3c).14 
Colorless prisms, mp = 169-172 ºC (from hexane/CDCl3); IR (neat) 
νmax 2979, 2937, 1729, 1714 cm-1; 1H NMR δH: 1.25–1.30 (m, 6H, 
2xCO2CH2CH3), 2.96, 3.36 (2xd, J = 13.9 Hz, 2H, CH2Ph), 3.51 (s, 
1H, NH), 3.55 [d, J = 7.8 Hz, 1H, CHC(CO2Et)Bn], 3.73 [deform. 
dd, J = 7.8, 7.8 Hz, 1H, CHCH(CO2Et)NH], 4.15–4.30 [m, 5H, 
2xCO2CH2CH3 and CH(CO2Et)NH], 7.15–7.49 (m, 10H, ArH); 13C 
NMR δC: 13.9, 14.0 (CO2CH2CH3), 42.3 (CH2Ph), 50.4 
[CHCH(CO2Et)NH], 56.6 [CHCH(CO2Et)NH], 62.1, 62.2 
(2xCO2CH2CH3), 62.3 [CH(CO2Et)NH], 74.1 [CBn(CO2Et)NH], 
126.6, 127.2, 128.0, 128.2, 128.9, 129.2, 130.4, 135.6 (ArC), 169.7, 
170.1 (2xCO2), 174.0, 174.2 (2xCON); MS (EI-GC) m/z: 450 (M++1, 
<1%), 377 (14), 360 (22), 359 (100), 207 (44), 166 (40), 156 (10), 
119 (10), 94 (13), 91 (45); HRMS calculated for C25H26N2O6: 
450.1791, found: 450.1801. 
4.2.16. 5-Ethyl 2,3,4-trimethyl (2S*,3S*,4S*,5R*)-2-
benzylpyrrolidine-2,3,4,5-tetracarboxylate (endo-cis-3d).14 Colorless 
oil; IR (neat) νmax 2983, 2954, 2906, 1732, 1727 cm-1; 1H NMR δH: 
1.22, 1.26 (2t, J = 7.1 Hz, 3H, CO2CH2CH3), 3.13, 3.37 (2d, J = 13.8 
Hz, 2H, CH2Ph), 3.34 [d, J = 10.1 Hz, 1H, CHC(CO2Et)Bn], 3.65 
[dd, J = 10.1, 8.5 Hz, 1H, CHCH(CO2Et)NH], 3.70, 3.78 (2s, 3H, 
CO2CH3), 3.86 [d, J = 8.5 Hz, 1H, CH(CO2Et)NH], 4.05–4.25 (m, 
4H, 2xCO2CH2CH3), 7.24–7.36 (m, 5H, ArH), NH nd; 13C NMR δC: 
14.0, 14.2 (2xCO2CH2CH3), 42.6 (CH2Ar), 49.3 [CHC(CO2Et)Bn], 
52.4, 52.6 (2xCO2CH3), 54.8 [CHCH(CO2Et)NH], 61.6 
[CH(CO2Et)NH], 62.0, 61.7 (2xCO2CH2CH3), 72.3 [C(CO2Et)Bn], 
127.1, 128.3, 130.9, 135.9 (ArC), 170.5, 171.9, 172.3, 172.9 
(4xCO2); MS (EI-GC) m/z: 407 (M++1, <1%), 348 (18), 330 (48), 
316 (44), 298 (100), 166 (32), 138 (11), 91 (60); HRMS calculated 
for C20H25NO8: 407.1580, found: 407.1586. 
4.2.17. Diethyl (2R*,3S*,4S*,5S*)-2-benzyl-3,4-bis(phenylsulfonyl) 
pyrrolidine-2,5-dicarboxylate (exo-cis-3e).14 Pale yellow prisms, mp: 
85-86 ºC (from n-hexane/ethyl acetate); IR (neat) νmax 2971, 1741, 
1235, 1149 cm-1; 1H NMR δH: 1.04 (t, J = 7.2 Hz, 1H, CO2CH2CH3), 
1.21 (t,  J = 7.2 Hz, 1H, CO2CH2CH3), 3.29, 3.40 (2xd, J = 14.2 Hz, 
2H, CH2Ph), 3.88–4.29 (m, 4H, 2xCO2CH2CH3), 4.20 
[CH(CO2Et)NH], 4.43 (br. s, 1H, NH), 4.51 [d, J = 5.2 Hz, 1H, 
CHC(CO2Et)Bn], 4.89 [deform. dd, J = 5.2, 5.2 Hz, 1H, 
CHCH(CO2Et)NH], 7.18–7.33 (m, 5H, ArH), 7.44 – 7.82 (m, 8H, 
ArH), 7.88–7.98 (m, 2H, ArH); 13C NMR δC: 13.8, 14.0 
(2xCO2CH2CH3), 41.0 (CH2Ph), 61.1, 62.2 (2xCO2CH2CH3), 62.3 
[CHCH(CO2Et)NH], 69.4 [CHCBn(CO2Et)NH], 72.0 
[CH(CO2Et)NH], 73.8 [CBn(CO2Et)NH], 127.4, 128.4, 128.8, 129.1, 














169.6 (2xCO2); MS (EI-GC) m/z: 585 (M++1, <1%), 512 (10), 494 
(34), 370 (14), 353 (13), 352 (69), 306 (33), 298 (10), 280 (26), 235 
(10), 234 (82), 157 (13), 156 (23), 141 (10), 125 (15), 112 (11), 94 
(16), 91 (100), 80 (12), 77 (29); HRMS calculated for C29H31NO8S2–
C3H5O2: 512.1202, found: 512.1215. 
4.2.18. 3-Ethyl 1-methyl (1R*,3R*,3aS*,6aR*)-5-methyl-4,6-dioxo-
1-phenyloctahydropyrrolo[3,4-c]pyrrole-1,3-dicarboxylate (endo-
cis-4a).14 Sticky pale yellow oil; IR (neat) νmax 2982, 2954, 1779, 
1736, 1698 cm-1; 1H NMR δH: 1.25 (t, J = 7.2 Hz, 3H, CO2CH2CH3), 
2.91 (s, 3H, NCH3), 3.37 [deform. dd, J = 8.5, 7.5 Hz, 1H, 
CHCHCO2Et], 3.69 (s, 3H, CO2CH3), 3.76 [d, J = 8.5, 1H, 
CH(CO2Et)NH], , 3.96 [d, J = 7.5, Hz, 1H, CH(CO2Me)Ph], 4.20 
(qd, J = 7.2, 1.1 Hz, 2H, CO2CH2CH3), 7.22–7.36 (m, 3H, ArH), 
7.58–7.63 (m, 2H, ArH), NH nd; 13C NMR δC: 14.2 (CO2CH2CH3), 
25.5 (NCH3), 50.3 [CHCH(CO2Et)NH], 53.4 [CHC(CO2Me)Ph], 
56.5 (CHCO2Et), 61.6 (CO2CH3), 62.1 (CO2CH2CH3), 74.8 
[C(CO2Me)Ph], 127.4, 128.5, 128.7, 138.1 (ArC), 169.6, 170.2 
(2xCO2), 175.1, 175.4 (2xCON); MS (EI-GC) m/z: 360 (M++1, 
<1%), 302 (17), 301 (100), 228 (14), 227 (72), 170 (19), 143 (18), 
142 (27); HRMS calculated for C18H20N2O6: 360.1321, found: 
360.1322. 
4.2.19. 3-Ethyl 1-methyl (1S*,3R*,3aS*,6aR*)-5-methyl-4,6-dioxo-1-
phenyloctahydropyrrolo[3,4-c]pyrrole-1,3-dicarboxylate (endo-
trans-4a).14 Sticky pale yellow oil; IR (neat) νmax 2983, 2954, 2926, 
1781, 1729, 1702 cm-1; 1H NMR δH: 1.39 (t, J = 7.2 Hz, 3H, 
CO2CH2CH3), 2.79 (s, 3H, NCH3), 3.08 (d, J = 3.5 Hz, 1H, NH), 
3.55 [deform. dd, J = 7.6, 7.6 Hz, 1H, CHCHCO2Et], 3.79 (s, 3H, 
CO2CH3), 3.86 [dd, J = 7.6, 3.5 Hz, 1H, CH(CO2Et)NH], 4.25 [d, J = 
7.6, Hz, 1H, CHC(CO2Me)Ph], 4.30–4.41 (m, 2H, CO2CH2CH3), 
7.33–7.41 (m, 3H, ArH), 7.47–7.54 (m, 2H, ArH); 13C NMR δC: 14.2 
(CO2CH2CH3), 25.2 (NCH3), 45.3 [CHCH(CO2Et)NH], 50.4 
[CHC(CO2Me)Ph], 53.7 (CHCO2Et), 59.8 (CO2CH3), 61.7 
(CO2CH2CH3), 74.1 [C(CO2Me)Ph], 126.0, 128.5, 128.9, 135.4 
(ArC), 169.3, 173.5 (2xCO2), 174.1, 175.6 (2xCON); MS (EI-GC) 
m/z: 360 (M++1, <1%), 302 (18), 301 (100), 228 (13), 227 (63), 170 
(20), 143 (22), 142 (30), 115 (15); HRMS calculated for 
C18H20N2O6: 360.1321, found:360.1336. 
4.2.20. 5-Ethyl 2,3,4-trimethyl (2R*,3S*,4S*,5R*)-2-
phenylpyrrolidine-2,3,4,5-tetracarboxylate (endo-cis-4d).14 Colorless 
oil; IR (neat) νmax 2984, 2954, 1735, 1716, 1713, 1700 cm-1; 1H 
NMR δH: 1.14 (t, J = 7.1 Hz, 3H, CO2CH2CH3), 3.64, 3.67, 3.75 (3s, 
3H, CO2CH3), 3.82 [dd, J = 10.1, 8.5 Hz, 1H, CHCH(CO2Et)NH], 
3.98 [d, J = 8.5 Hz, 1H, CH(CO2Et)NH], 4.04 (q, J = 7.1, Hz, 2H, 
CO2CH2CH3), 4.38 [d, J = 10.1 Hz, 1H, CHC(CO2Me)Ph], 7.26–
7.38 (m, 2H, ArH), 7.51 (dd, J = 8.5, 2.8 Hz, 1H, ArH), 7.70 (dd, J = 
8.5, 2.8 Hz, 2H, ArH), NH nd; 13C NMR δC: 14.0 (CO2CH2CH3), 
51.1, 52.3, 52.6 (3xCO2CH3), 53.3 [CHC(CO2Me)Ph], 53.5 
[CHCH(CO2Et)NH], 60.7 [CH(CO2Et)NH], 61.4 (CO2CH2CH3), 
75.0 [C(CO2Me)Ph], 127.0, 128.1, 128.3, 140.9 (ArC), 170.8, 171.3, 
171.7, 172.8 (4xCO2); MS (EI-GC) m/z: 393 (M++1, <2%), 335 (19), 
334 (100), 302 (24), 288 (11), 274 (35), 260 (25), 242 (13), 228 (51), 
202 (25), 201 (11), 170 (11), 143 (26), 115 (16); HRMS calculated 
for C19H23NO8: 393.1424, found: 393.1421. 
4.2.21. 5-Ethyl 2,3,4-trimethyl (2R*,3R*,4R*,5R*)-2-
phenylpyrrolidine-2,3,4,5-tetracarboxylate (exo-cis-4d).14 Colorless 
oil; IR (neat) νmax 2990, 2950, 1748, 1733, 1730, 1715 cm-1; 1H 
NMR δH: 1.30 (t, J = 7.1 Hz, 3H, CO2CH2CH3 CO2Et)NH], 4.86 [d, 
J = 5.3 Hz, 1H, CHC(CO2Me)Ph], 4.91 [deform. dd, J = 5.3, 5.0 Hz, 
1H, CHCHCO2Et], 7.35–8.05 (m, 15H, ArH), NH nd; 13C NMR δC: 
14.0 (CO2CH2CH3), 53.2 [CH(CO2Et)NH], 60.9 (CO2CH3), 62.3 
(CO2CH2CH3), 69.4 [CHCH(CO2Et)NH], 74.6 [CHC(CO2Me)Ph], 
75.1 [C(CO2Me)Ph], 128.2, 128.3, 128.6, 128.8, 128.9, 129.2, 129.3, 
134.0, 134.3, 136.8, 138.6, 140.1 (ArC), 170.0, 170.1 (2xCO2); MS 
(EI-GC) m/z: 557 (M++1, <1%), 357 (11), 356 (51), 342 (10), 310 
(15), 299 (11), 298 (54), 284 (17), 283 (21), 215 (37), 158 (11), 
157 (11), 144 (11), 143 (100), 142 (11), 115 (24), 77 (11); HRMS 
calculated for C27H27NO8S2:557.1168, found: 557.1173. 
4.2.22. 5-Ethyl 2,3-dimethyl (2R*,3R*,5R*)-2-phenylpyrrolidine-
2,3,5-tricarboxylate (endo-cis-4f).14  Yellowish oil; IR (neat) νmax 
2985, 2953, 1734, 1700 cm-1; 1H NMR δH: 1.29 (t, J = 7.1 Hz, 3H, 
CO2CH2CH3), 2.29–2.36 [m, 2H, CH2CH(CO2Et)], 3.51 [dd, J = 7.6, 
4.5 Hz, 1H, CHC(CO2Me)Ph], 3.68, 3.70 (2s, 3H, CO2CH3), 3.85 
[dd, J = 9.0, 5.7 Hz, 1H, CH(CO2Et)NH], 4.23 (q, J = 7.1, Hz, 2H, 
CO2CH2CH3), 7.25–7.35 (m, 3H, ArH), 7.73–7.77 (m, 2H, ArH), 
NH nd; 13C NMR δC: 14.3 (CO2CH2CH3), 33.8 
[CH2CH(CO2Et)NH], 52.2, 52.9 (2xCO2CH3), 54.0 
[CHC(CO2Me)Ph], 58.6 [CH(CO2Et)NH], 61.5 (CO2CH2CH3), 75.5 
[C(CO2Me)Ph], 126.9, 128.1, 128.4, 140.2 (ArC), 172.2, 173.1, 
173.6 (3xCO2); MS (EI-GC) m/z: 335 (M++1, <2%), 277 (18), 276 
(100), 262 (19), 202 (41), 170 (19), 144 (20), 143 (14), 115 (10), 99 
(15); HRMS calculated for C17H21NO6: 335.1369, found:335.1313. 
4.2.23. 5-Ethyl 2,3-dimethyl (2S*,3R*,5R*)-2-phenylpyrrolidine-
2,3,5-tricarboxylate (endo-trans-4f).14 Yellowish oil; Rf 0.29 (n-
hexane/ethyl acetate 7/3); IR (neat) νmax 2984, 2953, 1727, 1658 cm-
1; 1H NMR δH: 1.30 (t, J = 7.1 Hz, 3H, CO2CH2CH3), 2.36–2.46 [m, 
2H, CH2CH(CO2Et)], 3.19, 3.72 (2s, 3H, CO2CH3), 3.92 [deform. 
dd, J = 8.0, 7.6 Hz, Ph1H, CHC(CO2Me)Ph], 4.04 [deform. dd, J = 
6.5, 5.9 Hz, 1H, CH(CO2Et)NH], 4.26 (q, J = 7.1, Hz, 2H, 
CO2CH2CH3), 7.24–7.37 (m, 3H, ArH), 7.49–7.53 (m, 2H, ArH), 
NH nd; 13C NMR δC: 14.3 (CO2CH2CH3), 32.7 
[CH2CH(CO2Et)NH], 50.6, 51.5 (2xCO2CH3), 53.4 
[CHC(CO2Me)Ph], 58.5 [CH(CO2Et)NH], 61.3 (CO2CH2CH3), 76.0 
[C(CO2Me)Ph], 126.3, 128.3, 128.5, 137.5 (ArC), 172.6, 173.0, 
173.9 (3xCO2); MS (EI-GC) m/z: 335 (M++1, <2%), 277 (21), 276 
(100), 262 (15), 202 (38), 201 (10), 170 (25), 144 (13), 143 (11), 115 
(11), 99 (17); HRMS calculated for C17H21NO6: 335.1369, found: 
335.1308. 
4.2.24. 5-Ethyl 2-methyl (2R*,3R*,4R*,5S*)-2-phenyl-3,4-
bis(phenylsulfonyl)pyrrolidine-2,5-dicarboxylate (exo-trans-4e).14 
Orange oil; Rf 0.10 (n-hexane/ethyl acetate 7/3); IR (neat) νmax 2981, 
2954, 2926, 1738, 1692, 1309, 1147 cm-1; 1H NMR δH: 1.04 (t, J = 
7.2 Hz, 3H, CO2CH2CH3), 3.74 (s, 3H, CO2CH3), 4.01 (q, J = 7.2 
Hz, 2H, CO2CH2CH3), 4.35 [d, J = 5.0 Hz, 1H, CH(OMe)2)NH], 
3.40 [dd, J = 7.6, 4.8 Hz, 1H, CHCH(OMe)2NH], 3.42, 3.54 (2s, 6H, 
2xOCH3), 3.51 [deform. dd, J = 7.9, 7.6 Hz, 1H, CHCH(CO2Et)NH], 
3.85 [d, J = 7.6 Hz, 1H, CH(CO2Et)NH], 4.30 (q, J = 7.2 Hz, 2H, 
CO2CH2CH3), 4.69 [d, J = 4.8 Hz, 1H, CH(OMe)2]; 13C NMR δC: 
14.2 (CO2CH2CH3), 25.2 (NCH3), 45.5 [CHCH(OMe)2NH], 49.1 
[CHCH(CO2Et)NH], 55.8, 56.0 (2xOCH3), 61.7 (CO2CH2CH3), 62.3 
[CH(CH(OMe)2)NH], 63.4 [CH(CO2Et)NH], 102.6 [CH(OMe)2], 
169.6 (CO2Et), 175.6, 175.9 (2xCON); MS (EI-GC) m/z: 300 (M+, 
<1%), 269 (13), 225 (27), 195 (34), 179 (10), 151 (18), 94 (16), 75 




5a). Yellow prisms, mp: 105-108 ºC (from hexane/CH2Cl2); IR 
(neat)  νmax 2980, 1719, 1696 cm-1; 1H NMR δH: 1.35 (t, J = 7.2 Hz, 
3H, CO2CH2CH3), 2.50 (br. s, 1H, NH), 2.95 (s, 3H, NCH3), 3.27 
[deform. dd, J = 7.9, 7.6 Hz, 1H, CHCH(CH(), 3.56, 3.69, 3.72 (3s, 
3H, CO2CH3), 3.64 [deform. dd, J = 6.9, 6.7 Hz, 1H, 
CHCH(CO2Et)NH], 3.89 [d, J = 6.7 Hz, 1H, CHC(CO2Me)Ph], 4.17 
[d, J = 6.9 Hz, 1H, CH(CO2Et)NH], 4.26 (q, J = 7.1, Hz, 2H, 
CO2CH2CH3), 7.28–7.38 (m, 2H, ArH), 7.51 (dd, J = 7.0, 2.3 Hz, 
1H, ArH), 7.70 (dd, J = 7.0, 2.3 Hz, 2H, ArH), NH nd; 13C NMR δC: 
14.3 (CO2CH2CH3), 51.8, 52.6, 52.8 (3xCO2CH3), 53.6 
[CHC(CO2Me)Ph], 54.7 [CHCH(CO2Et)NH], 61.6 [CH(CO2Et)NH], 














(ArC), 171.1, 171.6, 172.0, 172.1 (4xCO2); MS (EI-GC) m/z: 393 
(M++1, <1%), 335 (19), 334 (100), 303 (11), 302 (60), 274 (14), 260 
(25), 242 (11), 228 (27), 202 (21), 170 (56), 143 (24), 115 (14); 
HRMS calculated for C19H23NO8: 393.1424, found: 393.1426. 
4.2.26. Ethyl (1S*,3R*,3aS*,6aR*)-5-benzyl-3-(dimethoxymethyl)-
4,6-dioxooctahydropyrrolo[3,4-c]pyrrole-1-carboxylate (endo-cis-
5b). Sticky pale yellow oil; IR (neat)  νmax 2968, 2308, 1716, 1695 
cm-1; 1H NMR δH: 1.32 (t, J = 7.2 Hz, 3H, CO2CH2CH3), 2.50 (br. s, 
1H, NH), 3.16, 3.47 (2s, 6H, 2xOCH3), 3.25 [deform. dd, J = 8.0, 7.7 
Hz, 1H, CHCH(CH(OMe)2)NH], 3.40 [dd, J = 8.0, 4.0 Hz, 1H, 
CHCH(OMe)2NH], 3.51 [deform. dd, J = 7.7, 7.6 Hz, 1H, 
CHCH(CO2Et)NH], 3.87 [d, J = 7.6 Hz, 1H, CH(CO2Et)NH], 4.29 
(q, J = 7.2 Hz, 2H, CO2CH2CH3), 4.54 (d, J = 14.3 Hz, 1H, 
NCHHPh), 4.65 [d, J = 4.0 Hz, 1H, CH(OMe)2], 4.68 (d, J = 14.3 
Hz, 1H, NCHHPh) 7.23-7.34 (m, 5H, ArH); 13C NMR δC: 14.2 
(CO2CH2CH3), 42.7 (NCH2Ph), 46.8 [CHCH(CH(OMe)2)NH], 49.4 
[CHCH(CO2Et)NH], 55.4, 55.7 (2xOCH3), 61.6 (CO2CH2CH3), 62.7 
[CH(CH(OMe)2)NH], 63.7 [CH(CO2Et)NH], 102.0 [CH(OMe)2], 
127.9, 128.5, 128.6, 135.6 (ArC), 169.4 (CO2Et), 175.3, 175.5 
(2xCON); MS (EI-GC) m/z: 376 (M+, <1%), 301 (29), 271 (15), 243 
(10), 227 (18), 94 (10), 75 (100); HRMS calculated for 
C19H24N2O6+1: 377.1712, found: 377.1701. 
4.2.27. Ethyl (1S*,3R*,3aS*,6aR*)-3-(dimethoxymethyl)-4,6-dioxo-
5-phenyloctahydropyrrolo[3,4-c]pyrrole-1-carboxylate (endo-cis-
5c). Yellowish prisms, mp: 98-102 ºC (from hexane/CH2Cl2); IR 
(neat)  νmax 2995, 2939, 2310, 1718, 1700 cm-1; 1H NMR δH: 1.32 (t, 
J = 7.2 Hz, 3H, CO2CH2CH3), 2.55 (br. s, 1H, NH), 3.39 (s, 3H, 
OCH3), 3.43 [deform. dd, J = 7.7, 7.2 Hz, 1H, 
CHCH(CH(OMe)2)NH], 3.50-3.55 (m, 4H, CHCH(OMe)2NH, 
OCH3), 3.66 [deform. dd, J = 7.7, 7.2 Hz, 1H, CHCH(CO2Et)NH], 
3.97 [d, J = 7.7 Hz, 1H, CH(CO2Et)NH], 4.28 (q, J = 7.2 Hz, 2H, 
CO2CH2CH3), 4.79 [d, J = 4.0 Hz, 1H, CH(OMe)2], 7.24-7.51 (m, 
5H, ArH); 13C NMR δC: 14.2 (CO2CH2CH3), 47.1 
[CHCH(CH(OMe)2)NH], 49.5 [CHCH(CO2Et)NH], 55.8, 55.9 
(2xOCH3), 61.8 (CO2CH2CH3), 62.9 [CH(CH(OMe)2)NH], 64.1 
[CH(CO2Et)NH], 102.2 [CH(OMe)2], 126.7, 128.9, 129.3, 131.9 
(ArC), 169.6 (CO2Et), 174.8, 175.0 (2xCON); MS (EI-GC) m/z: 362 
(M+, <1%), 331 (11), 287 (29), 257 (24), 94 (21), 75 (100); HRMS 
calculated for C18H22N2O6+1: 363.1556, found: 363.1550.  
4.2.28. Methyl (1S*,3R*,3aS*,6aR*)-3-(dimethoxymethyl)-1,5-
dimethyl-4,6-dioxooctahydropyrrolo[3,4-c]pyrrole-1-carboxylate 
(endo-cis-6a). Yellow solid, mp: 120-123 ºC (from hexane/CH2Cl2); 
IR (neat)  νmax 2976, 1720, 1702 cm-1; 1H NMR δH: 1.47 [s, 3H, 
C(CO2CH3)CH3], 2.92 (s, 3H, NCH3), 3.20 [d, J = 7.7 Hz, 1H, 
CHC(CO2Me)CH3], 3.34 [deform. dd, J = 8.6, 7.7 Hz, 1H, 
CHCH(CH(OMe)2)NH], 3.38 3.51 (2s, 6H, 2xOCH3), 3.68 (dd, J = 
8.6, 3.0 Hz, 1H, CHCH(OMe)2NH), 3.83 (s, 3H, CO2CH3), 4.76  [d, 
J = 3.0 Hz, 1H, CH(OMe)2], NH nd; 13C NMR δC: 24.1 
[C(CO2CH3)CH3], 25.1 (NCH3), 47.6 [CHCH(CH(OMe)2)NH], 52.9 
[CHC(CO2Me)CH3],  55.7, 56.0 (2xOCH3), 56.7 (CO2CH3), 62.4 
[CH(CH(OMe)2)NH], 68.3 [C(CO2Me)CH3], 101.9 [CH(OMe)2], 
172.3 (CO2Me), 175.7, 176.1 (2xCON); MS (EI-GC) m/z: 300 (M+, 
<1%), 241 (13), 225 (37), 209 (24), 165 (40), 108 (20), 75 (100); 
HRMS calculated for C13H20N2O6+1: 301.1399, found: 301.1392.  
4.2.29. Trimethyl (2S*,3S*,4S*,5R*)-5-(dimethoxymethyl)-2-
methylpyrrolidine-2,3,4-tricarboxylate (endo-cis-6d). Sticky pale 
yellow oil; IR (neat)  νmax 2987, 1715, 1713, 1692 cm-1; 1H NMR δH: 
1.60 [s, 3H, C(CO2CH3)CH3], 3.25 [deform. dd, J = 10.5, 8.3 Hz, 
1H, CHCH(CH(OMe)2)NH], 3.34 [d, J = 10.5 Hz, 1H, 
CHC(CO2Me)CH3], 3.40 (s, 6H, 2xOCH3), 3.60 (dd, J = 8.3, 6.2 Hz, 
1H, CHCH(OMe)2NH), 3.68 (s, 6H, 2xCO2CH3), 3.74 (s, 3H, 
CO2CH3), 4.33  [d, J = 6.2 Hz, 1H, CH(OMe)2], NH nd; 13C NMR 
δC: 25.6 [C(CO2CH3)CH3], 49.2 [CHCH(CH(OMe)2)NH], 52.2 
[CHC(CO2Me)CH3],  52.3, 52.4 (2xOCH3), 54.5, 55.5, 58.0 
(3xCO2CH3), 62.3 [CH(CH(OMe)2)NH], 67.9 [C(CO2Me)CH3], 
106.1 [CH(OMe)2], 171.0, 173.4, 174.4 (3xCO2Me); MS (EI-GC) 
m/z: 333 (M+, <1%), 258 (11), 215 (15), 200 (12), 156 (31), 75 




(endo-cis-7a). Yellowish prisms, mp: 85-88 ºC (from 
hexane/CH2Cl2); IR (neat)  νmax 2988, 2335, 1717, 1699 cm-1; 1H 
NMR δH: 1.34 (t, J = 7.2 Hz, 3H, CO2CH2CH3), 2.79 (br s, 1H, NH), 
2.92 (d, J = 13.7 Hz, 1H, CHHPh), 2.93 (s, 3H, NCH3), 3.30-3.35 
[m, 6H, CHHPh, CHCH(CH(OMe)2)NH, CHC(CO2Et)BnNH, 
OCH3],  3.49 (s, 3H, OCH3), 3.66 [m, 1H, CHCH(OMe)2NH], 4.26 
(q, J = 7.2 Hz, 2H, CO2CH2CH3), 4.68  [d, J = 4.1 Hz, 1H, 
CH(OMe)2], 7.19-7.30 (m, 5H, ArH);  13C NMR δC: 14.2 
(CO2CH2CH3), 24.2 (NCH3), 41.0 [CHC(CO2Et)BnNH], 47.1 
[CHCH(CH(OMe)2)NH], 55.0 (CH2Ph), 55.7, 55.8 (2xOCH3), 61.5 
(CO2CH2CH3), 61.9 [CH(CH(OMe)2)NH], 74.2 [C(CO2Et)BnNH], 
102.1 [CH(OMe)2], 127.3, 128.5, 130.2, 135.8 (ArC), 170.7 (CO2Et), 
175.5, 175.9 (2xCON); MS (EI-GC) m/z: 390 (M+, <1%), 315 (26), 
299 (27), 285 (13), 269 (14), 268 (14), 267 (100), 91 (13), 75 (13); 
HRMS calculated for C20H26N2O6+1: 391.1869, found: 391.1875. 
4.2.31. Ethyl (1S*,3R*,3aS*,6aR*)-1,5-dibenzyl-3-
(dimethoxymethyl)-4,6-dioxooctahydropyrrolo[3,4-c]pyrrole-1-
carboxylate (endo-cis-7b). Yellowish prisms, mp: 92-94 ºC (from 
hexane/CH2Cl2); IR (neat)  νmax 2996, 2938, 2310, 1715, 1700 cm-1; 
1H NMR δH: 1.29 (t, J = 7.2 Hz, 3H, CO2CH2CH3), 2.86 (br s, 1H, 
NH), 2.92 (d, J = 13.8 Hz, 1H, CHHPh), 3.08, 3.41 (2s, 6H, 
2xOCH3), 3.28-3.35 [m, 3H, CHHPh, CHCH(CH(OMe)2)NH, 
CHC(CO2Et)BnNH], 3.63 [dd, J = 7.4, 3.8 Hz, 1H, 
CHCH(OMe)2NH], 4.23 (q, J = 7.2 Hz, 2H, CO2CH2CH3), 4.54, 
4.66 (d, J = 14.4 Hz, 2H, NCH2Ph), 4.61  [d, J = 3.8 Hz, 1H, 
CH(OMe)2], 7.20-7.33 (m, 10H, ArH);  13C NMR δC: 14.1 
(CO2CH2CH3), 41.1, 42.7 (CH2Ph, NCH2Ph), 47.1 
[CHC(CO2Et)BnNH], 54.5 [CHCH(CH(OMe)2)NH], 55.4, 55.6 
(2xOCH3), 61.8 [CH(CH(OMe)2)NH], 62.0 (CO2CH2CH3), 72.5 
[C(CO2Et)BnNH], 101.7 [CH(OMe)2], 127.2, 127.9, 128.4, 128.5, 
128.6, 130.2, 135.6, 135.9 (ArC), 170.6 (CO2Et), 175.2, 175.5 
(2xCON); MS (EI-GC) m/z: 466 (M+, <1%), 308 (12), 307 (55), 290 
(16), 289 (100), 281 (11), 215 (14), 207 (21), 187 (12), 174 (15), 119 




(endo-cis-7c). Yellowish solid, mp: 118-121 ºC (from 
hexane/CH2Cl2); IR (neat)  νmax 2992, 2945, 2315, 1718, 1689 cm-1; 
1H NMR δH: 1.33 (t, J = 7.2 Hz, 3H, CO2CH2CH3), 3.01, 3.39 (2d, J 
= 13.7 Hz, 2H, CH2Ph), 3.34, (s, 3H, OCH3), 3.47-3.53 [m, 5H, 
CHCH(CH(OMe)2)NH, CHC(CO2Et)BnNH, OCH3], 3.74 [dd, J = 
7.8, 3.4 Hz, 1H, CHCH(OMe)2NH], 4.26  (qd, J = 7.2, 2.1 Hz, 2H, 
CO2CH2CH3), 4.82 [d, J = 3.8 Hz, 1H, CH(OMe)2], 7.23-7.50 (m, 
10H, ArH), NH nd;  13C NMR δC: 14.0 (CO2CH2CH3), 41.3 
(CH2Ph), 47.5 [CHC(CO2Et)BnNH], 54.7 [CHCH(CH(OMe)2)NH], 
55.6, 56.0 (2xOCH3), 62.0 [CH(CH(OMe)2)NH], 62.2 
(CO2CH2CH3), 72.8 [C(CO2Et)BnNH], 101.6 [CH(OMe)2], 126.6, 
127.2, 128.3, 128.8, 129.2, 130.2, 131.8, 135.8 (ArC), 170.6 
(CO2Et), 174.6, 174.9 (2xCON); MS (EI-GC) m/z: 452 (M+, <1%), 
315 (23), 299 (24), 285 (13), 269 (15), 268 (15), 267 (100), 241 (10), 
91 (29), 75 (35); HRMS calculated for C25H28N2O6+1: 453.2025, 
found: 453.2014.  
4.2.33. 2-Ethyl 3,4-dimethyl (2S*,3R*,4R*,5R*)-2-benzyl-5-
(dimethoxymethyl)pyrrolidine-2,3,4-tricarboxylate (exo-cis-7d). 
Sticky pale yellow oil; IR (neat)  νmax 2985, 2947, 1714, 1712, 1691 














(d, J = 13.0 Hz, 2H, CH2Ph), 3.29, 3.34 (s, 6H, 2xOCH3), 3.68-3.73 
[m, 6H, CHCH(CH(OMe)2)NH, CHC(CO2Et)BnNH, 
CHCH(OMe)2NH, CO2CH3], 3.79 (s, 3H, CO2CH3), 4.07-4.23  [m, 
3H, CH(OMe)2, CO2CH2CH3], 7.16-7.22 (m, 5H, ArH), NH nd;  13C 
NMR δC: 14.2 (CO2CH2CH3), 42.0 (CH2Ph), 47.9 
[CHC(CO2Et)BnNH], 52.0 [CHCH(CH(OMe)2)NH], 52.4, 53.1 
(2xCOCH3), 54.5, 54.8 (2xOCH3), 59.7 [CH(CH(OMe)2)NH], 61.7 
(CO2CH2CH3), 69.9 [C(CO2Et)BnNH], 103.8 [CH(OMe)2], 126.8, 
128.0, 130.6, 136.3 (ArC), 171.3, 171.6 (2xCO2Me), 174.1 (CO2Et); 
MS (EI-GC) m/z: 423 (M+, <1%), 392 (14), 350 (19), 348 (45), 332 
(36), 318 (21), 317 (13), 316 (68), 301 (11), 300 (76), 288 (39), 286 
(11), 268 (59), 258 (26), 256 (15), 242 (16), 240 (15), 226 (20), 224 
(11), 216 (11), 210 (18), 196 (13), 194 (17), 166 (11), 91 (100), 75 
(28); HRMS calculated for C21H29NO8+1: 424.1971, found: 
424.1968.  
4.2.34. 2-Ethyl 3,4-dimethyl (2S*,3S*,4S*,5R*)-2-benzyl-5-
(dimethoxymethyl)pyrrolidine-2,3,4-tricarboxylate (endo-cis-7d). 
Sticky pale yellow oil; IR (neat)  νmax 2987, 2955, 1719, 1716, 1696 
cm-1; 1H NMR δH: 1.24 (t, J = 7.1 Hz, 3H, CO2CH2CH3), 2.61 (br s, 
1H, NH), 3.12-1.19 [m, 2H, CHHPh, CHCH(CH(OMe)2)NH], 3.29-
3.40 [m, 9H, CHHPh, CHC(CO2Et)BnNH, CHCH(OMe)2NH, 
2xOCH3], 3.69 (s, 3H, CO2CH3), 3.77 (s, 3H, CO2CH3), 4.05-4.15 
[m, 2H, CO2CH2CH3], 4.36 [d, J = 6.4 Hz, 1H, CH(OMe)2], 7.17-
7.27 (m, 5H, ArH);  13C NMR δC: 14.1 (CO2CH2CH3), 43.1 (CH2Ph), 
49.0 [CHC(CO2Et)BnNH], 52.2, 52.3 (2xCOCH3), 53.8 
[CHCH(CH(OMe)2)NH], 55.2, 55.7 (2xOCH3), 61.7 
[CH(CH(OMe)2)NH], 61.9 (CO2CH2CH3), 72.0 [C(CO2Et)BnNH], 
105.9 [CH(OMe)2], 127.1, 128.3, 130.7, 136.1 (ArC), 171.1, 173.1 
(2xCO2Me), 173.4 (CO2Et); MS (EI-GC) m/z: 423 (M+, <1%), 348 
(11), 333 (11), 332 (65), 316 (33), 300 (45), 288 (46), 286 (11), 268 
(61), 258 (33), 256 (14), 242 (14), 240 (17), 226 (21), 216 (12), 210 
(17), 194 (16), 166 (10), 91 (100), 75 (27); HRMS calculated for 
C21H29NO8+1: 424.1971, found: 424.1959.  
4.2.35. Diethyl (3R*,3aS*,6aR*)-3-(dimethoxymethyl)-5-methyl-4,6-
dioxohexahydropyrrolo[3,4-c]pyrrole-1,1(2H)-dicarboxylate (all-
cis-8). Sticky pale yellow oil; IR (neat)  νmax 2999, 1718, 1713, 1691 
cm-1; 1H NMR δH: 1.29 (t, J = 7.1 Hz, 3H, CO2CH2CH3), 1.33 (t, J = 
7.1 Hz, 3H, CO2CH2CH3), 2.97 (s, 3H, NCH3), 3.32 (deform. dd, J = 
7.8, 7.5 Hz, 1H, CHCHNH), 3.42, 3.54 (2s, 6H, 2xOCH3), 4.08 [d, J 
= 7.5 Hz, 1H, CHC(CO2Et)2NH], 4.18-4.40 (m, 5H, CHNH, 
2xCO2CH2CH3), 4.56 [d, J = 6.1 Hz, 1H, CH(OMe)2], NH nd; 13C 
NMR δC: 14.1, 14.2 (2xCO2CH2CH3), 25.4 (NCH3), 45.5 
(CHCHNH), 50.6 [CHC(CO2Et)2NH], 55.5, 56.2 (2xOCH3), 60.9 
(CHNH), 62.6, 62.9 (2xCO2CH2CH3), 74.1 [C(CO2Et)2], 103.5 
[CH(OMe)2], 166.9, 169.3 (2xCO2Et), 175.2, 175.4 (2xCON); MS 
(EI-GC) m/z: 372 (M+, <1%), 341 (14), 299 (24), 298 (10), 297 (52), 
268 (10), 267 (65), 166 (30), 75 (100); HRMS calculated for 
C16H24N2O8+1: 373.1611, found: 373.1599. 
4.2.36. Methyl (1S*,3R*,3aS*,6aR*)-3-benzoyl-5-methyl-4,6-
dioxooctahydropyrrolo[3,4-c]pyrrole-1-carboxylate (endo-cis-9a). 
Pale yellow oil; IR (neat) νmax: 2359, 1749, 1693, 1676, 1435, 1286, 
1209, 1129, 701 cm-1;  1H-RMN δH: 2.92 (s, 3H, NMe), 3.01 (br. s, 
1H, NH), 3.10-2.95, 3.80-3.74 (2m, 2H, 2xCHCON), 3.83 (s, 3H, 
OMe), 4.46 (d, J = 1.0 Hz, 1H, 2xCHCON), 5.11 (d, J = 7.6 Hz, 1H, 
CHCOPh), 7.55-7.49 (m, 2H, ArH), 7.67-7.60 (m, 1H, ArH), 8.02-
7.97 (m, 2H, ArH); 13C-RMN δC: 25.6 (CH3N), 50.1 (CH3O), 50.7, 
53.1 (2xCCHON), 62.7, 64.6 (2xCHN), 128.3, 129.0, 134.1, 136.1 
(ArC), 172.4, 175.1, 176.6, 195.8 (4xCO); MS (EI) m/z (%): 316 
(M+, 1%), 211 (100), 151 (18), 105 (20), 94 (25), 77 (13); HRMS 
calculated for (C16H16N2O5): 316.1059, found: 316.1049. 
4.2.37. Methyl (1S*,3R*,3aR*,6aS*)-3-benzoyl-5-methyl-4,6-
dioxooctahydropyrrolo[3,4-c]pyrrole-1-carboxylate (exo-cis-9a). 
Pale yellow oil; IR (neat) νmax: 2356, 1701, 1441, 1382, 1265, 1125, 
732, 699 cm-1; 1H-RMN δH  2.59 (br. S, 1H, NH), 3.03 (s, 3H, MeN), 
3.56 (t, J = 8.0 Hz, 1H, CHCON), 3.73 (dd, J = 8.0, 1.5 Hz, 1H, 
CHCON), 3.82 (s, 3H, OMe), 4.21 (d, J = 8.1 Hz, 1H, CHCO2), 5.18 
(d, J = 1.6 Hz, 1H, CHCOPh), 7.56-7.50 (m, 2H, ArH), 7.66-7.61 
(m, 1H, ArH), 8.19-8.15 (m, 2H, ArH); 13C-RMN δC: 25.7 (MeN), 
48.2, 49.7 (2xCHCON), 52.7 (MeO), 61.8, 65.0 (2xCHN), 129.1, 
129.4, 133.4, 134.3 (ArC), 170.4, 175.6, 177.5, 196.7 (4xCO);  MS 
(EI) m/z (%): 316 (M+ 1%), 211 (100), 179 (26), 151 (40), 105 (13), 
94 (36), 77 (12); HRMS calculated for (C16H16N2O5): 316.1059, 
found: 316.1057.  
4.2.38. Methyl (1S*,3R*,3aS*,6aR*)-3-benzoyl-5-benzyl-4,6-
dioxooctahydropyrrolo[3,4-c]pyrrole-1-carboxylate (endo-cis-9b). 
Pale yellow oil; IR (neat) νmax: 1735, 1699, 1677, 1438, 1403, 1349, 
1288, 1170, 701 cm-1; 1H-RMN δH: 2.86 (br. S, 1H, NH), 3.69 (dd, J 
= 8.3, 8.1 Hz, 1H, CHCON), 3.80 (s, 3H, OMe), 3.83 (dd, J = 8.3, 
8.1 Hz, 1H, CHCON), 4.25 (d, J = 8.3 Hz, 1H, CHCO2), 4.51, 4.58 
(2d, J = 14.0 Hz, 2H CH2Ph), 5.09 (d, J = 8.3 Hz, 1H, CHCOPh), 
7.29-7.27 (m, 5H, ArH), 7.33-7.30 (m, 1H, ArH), 7.52 (t, J = 7.6 Hz, 
2H, ArH), 7.66-7.60 (m, 1H, ArH), 8.03-7.98 (m, 2H, ArH); 13C-
RMN δC: 43.2 (CH2Ph), 49.8, 50.5 (2xCHCON), 51.1 (MeO), 62.7, 
64.8 (2xCHN), 128.2, 128.4, 128.8, 128.8, 129.2, 134.3, 135.2, 135.7 
(ArC), 169.0, 175.8, 176.0, 195.0 (4xCO); MS (EI) m/z (%): 392 
(M+, 1%), 288 (17), 287 (100), 227 (44), 105 (16), 94 (21), 91 (42), 




Sticky oil; IR (neat) νmax: 1707, 1669, 1389, 1326, 1290, 1192, 1174, 
697 cm-1; 1H-RMN δH: 3.68 (br. s, 1H, NH), 3.81 (dd, J = 8.0, 7.9 
Hz, 1H, CHCON), 3.86 (s, 3H, OMe), 3.92 (t, J = 8.0 Hz, 1H, 
CHCON), 4.31 (d, J = 8.0 Hz, 1H, CHCO2), 5.15 (d, J = 7.9 Hz, 1H, 
CHCOPh), 7.19-7.13 (m, 2H, ArH), 7.45-7.31 (m, 4H, ArH), 7.50 (t, 
J = 7.5 Hz, 2H, ArH), 7.65-7.58 (m, 1H, ArH), 8.03-7.97 (m, 2H, 
ArH); 13C-RMN δC: 50.6 (CHCON), 51.1 (MeO), 52.8 (CHCON), 
63.0, 65.0 (2xCHN), 126.4, 128.2, 128.9, 129.2, 131.1, 134.1, 135.6, 
169.4 (ArC), 173.5, 174.0, 174.5, 194.8 (4xCO); MS (EI) m/z (%): 
378 (M+, 1%), 273 (100), 241 (15), 213 (15), 126 (13), 110 (25), 94 




Pale yellow oil; IR (neat) νmax: 1752, 1698, 1681, 1436, 1281, 1142, 
786, 699 cm-1; 1H-RMN δH: 1.63 (s, 3H, MeC), 2.40 (br. S, 1H, NH), 
2.87 (s, 3H, MeN), 3.36 (d, J = 7.7 Hz, 1H, CHCON), 3.91-3.81 (m 
with s at 3.80, MeO and CHCON), 5.16 (d, J = 8.3 Hz, 1H, CHN), 
7.53 (t, J = 7.5 Hz, 2H, ArH), 7.68-7.61 (m, 1H, ArH), 8.05-8.00 (m, 
2H, ArH); 13C-RMN δC: 25.0 (MeC), 25.4 (MeN), 51.7 (OMe), 53.2, 
57.9 (2xCHCON), 63.6, 69.2 (CHNC), 128.4, 129.1, 134.1, 136.1 
(ArC), 171.6; 174.5; 175.0; 195.2 (4xCO); MS (EI) m/z (%): 330 
(M+, 1%), 269 (17%), 225 (100%), 165 (87), 108 (38), 105 (57), 80 




Pale yellow oil; IR (neat) νmax: 1700, 1684, 1434, 1268, 1129, 1002, 
699 cm-1; 1H-RMN δH: 1.37 (t, J = 7.2 Hz, 3H, CH3CH2), 2.80 (br. s, 
1H, NH), 2.88 (s, 3H, MeC), 3.18, 3.41 (2xd, J = 13.9 Hz, 2H, 
CH2Ph), 3.57 (d, J = 7.7 Hz, 1H, CHCON), 3.66 (dd, J = 8.4, 7.7 Hz, 
1H, CHCON), 4.30 (qd, J = 7.2, 2.0 Hz, 2H, CH2Me), 4.87 (d, J = 
8.4 Hz, 1H, CHN), 7.39-7.29 (m, 5H, ArH), 7.58-7.50 (m, 2H, ArH), 
7.69-7.62 (m, 1H, ArH), 7.91 (dd, J = 5.3, 3.3, 2H, ArH); 13C-RMN  
δC: 14.0 (MeC), 25.2 (MeN), 42.9 (CH2Ph), 51.9 (CHCON), 57.1 
(CHCON), 62.4 (CH2O), 63.2, 73.3 (CHNC), 127.2, 128.1, 128.2, 
128.9, 130.5, 133.9, 135.9, 136.0 (ArC), 170.1, 174.4, 174.8, 195.2 














(100), 269 (36), 241 (30), 184 (20), 156 (25), 105 (46), 91 (43), 




Pale yellow oil; IR (neat) νmax: 1712, 1683, 1497, 1384, 1231, 1002, 
699 cm-1;  1H-RMN δH: 1.31 (t, J = 7.2 Hz, 3H, CH3CH2), 2.40 (br. s, 
1H, NH), 3.21, 3.42 (2xd, J = 13.8 Hz, 2H, CH2Ph), 3.08-3.68 (m, 
2H, 2xCHCON), 4.27 (dq, J = 7.2, 3.7 Hz, 2H, CH3CH2), 4.92 (d, J 
= 8.1 Hz, 1H, CHN), 7.16-7.11 (m, 2H, ArH), 7.43-7.28 (m, 8H, 
ArH), 7.53-7.45 (m, 2H, ArH), 7.64-7.57 (m, 1H, ArH), 7.88 (dd, J = 
5.2, 3.3 Hz, 2H, ArH); 13C-RMN δC: 13.9 (MeC), 43.1 (CH2Ph), 
51.9, 57.2 (2xCHCON), 62.5 (CH2O), 63.7, 73.9 (CHNC), 126.5, 
127.2, 128.2, 128.3, 128.8, 128.9, 129.1, 130.6, 131.2, 133.9, 135.9, 
136.0 (ArC), 170.3, 173.6, 174.0, 195.0 (4xCO); MS (EI) m/z (%): 
482 (M+ 1%), 409 (10), 392 (14), 391 (57), 378 (23), 377 (100), 331 
(23), 303 (28), 184 (25), 156 (18), 105 (83), 91 (41), 77 (23); HRMS 
calculated for (C29H26N2O5-1): 481.1842, found: 481.1832. 
4.2.43. 2-Ethyl 3,4-dimethyl (1S*,3R*,3aS*,6aR*)-5-benzoyl-2-
benzylpyrrolidine-2,3,4-tricarboxylate (endo-cis-11c). Pale sticky 
oil; IR (neat) νmax: 1733, 1436, 1265, 1203, 732, 700 cm-1;  1H-RMN  
for major endo isomer,  δH: 1.31-1.17 (m, 3H, CH3CH2), 2.10 (br. s, 
1H, NH), 3.22, 3.35 (2xd, J = 13.5 Hz, 2H, CH2Ph), 3.43 (s, 3H, 
MeO), 3.62-3.58 (m, 1H, CHCO2), 3.77 (s, 3H, MeO), 3.81 (d, J = 
4.8 Hz, 1H, CHCO2), 4.19-4.03 (m, 2H, CH2O), 4.68 (d, J = 8.8 Hz, 
1H, CHN), 7.23-7.14 (m, 2H, ArH), 7.33-7.24 (m, 5H, ArH), 7.40-
7.35 (m, 2H, ArH), 7.50-7.43 (m, 4H, ArH), 7.61-7.53 (m, 2H, ArH), 
7.88-7.82 (m, 2H, ArH); 13C-RMN for major endo isomer δC: 14.0 
(MeC), 42.9 (CH2Ph), 49.7 , 52.3, 52.4, 55.3 (2xMeO and 
2xCHCO2Me), 62.2 (CH2O), 64.1, 72.5 (CHNC), 127.2, 128.2, 
128.7, 128.8, 130.9, 133.8, 135.5, 135.9 (ArC), 170.6, 172.3, 172.4, 
196.8 (4xCO); MS (EI) m/z (%): 453 (M+, 6%), 360 (15), 346 (21), 
300 (20), 286 (22), 105 (100), 91 (96), 77 (46); HRMS calculated for 
(C25H27NO7-2): 451.1788, found: 451.1788. 
4.2.44. Diethyl (3R*,3aS*,6aR*)-3-benzoyl-5-methyl-4,6-
dioxohexahydropyrrolo[3,4-c]pyrrole-1,1(2H)-dicarboxylate (all-
cis-12a). Colorless oil; IR (neat) νmax: 1748, 1700, 1685, 1275, 1212, 
1173, 1109, 998, 772, 700 cm-1; 1H-RMN δH: 1.42-1.29 (m, 6H, 
2xCH3C); 2.00 (br. s, 1H, NH), 2.90 (s, 3H, MeN), 3.88 (d, J = 8.1 
Hz, 1H, CHCON), 4.23 (dd, J = 8.5, 8.1 Hz, 1H, CHCON), 4.52-
4.30 (m, 4H, 2xCH2), 4.87 (d, J = 8.5 Hz, 1H, CHN), 7.54 (t, J = 7.5 
Hz, 2H, ArH), 7.69-7.61 (m, 1H, ArH), 8.02-7.96 (m, 2H, ArH); 13C-
RMN δC: 14.1, 14.2 (2xCH3C), 25.5 (MeN), 51.3, 53.1 (2xCHCON), 
63.1, 63.2 (2xCH2), 63.4, 75.6 (CHNC), 128.3, 129.1, 134.2, 135.9 
(ArC), 166.5, 169.1, 174.4, 174.6, 194.6 (5xCO); MS (EI) m/z (%): 
402 (M+, 1%), 329 (12), 297 (100), 223 (10), 166 (62), 138 (10), 105 
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1H-, 13C-NMR Spectra and Bidimensional Experiments 
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